Related references
Note: Only part of the references are listed.Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem
Sunghwan Suh et al.
ENDOCRINOLOGY AND METABOLISM (2017)
Safety, pharmacokinetics and pharmacodynamics of BI 135585, a selective 11β-hydroxysteroid dehydrogenase-1 (HSD1) inhibitor in humans: liver and adipose tissue 11β-HSD1 inhibition after acute and multiple administrations over 2 weeks
S. Freude et al.
DIABETES OBESITY & METABOLISM (2016)
Association Between Pituitary-Adrenal Axis Dominance Over the Renin-Angiotensin-Aldosterone System and Hypertension
Makoto Daimon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme
Andre Otavio Peres Protzek et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Limiting glucocorticoid secretion increases the anorexigenic property of Exendin-4
Shin J. Lee et al.
MOLECULAR METABOLISM (2016)
Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population
Aya Kamba et al.
PLOS ONE (2016)
Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence
Aoibhe M. Pasieka et al.
METABOLITES (2016)
Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study
Makoto Daimon et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
Safety, efficacy and weight effect of two 11β-HSD1 inhibitors in metformin-treated patients with type 2 diabetes
T. Heise et al.
DIABETES OBESITY & METABOLISM (2014)
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes
Alex Rafacho et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Regulation of Aldosterone Synthesis and Secretion
Wendy B. Bollag
COMPREHENSIVE PHYSIOLOGY (2014)
20/(fasting C-peptide x fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
Tsuyoshi Ohkura et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus The ADVANCE Trial
Jun Hata et al.
CIRCULATION (2013)
Aldosterone Excess Impairs First Phase Insulin Secretion in Primary Aldosteronism
Evelyn Fischer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Clinical Safety, Pharmacokinetics, and Pharmacodynamics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 in Healthy Volunteers and Elderly Adults
Wei Liu et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2013)
Novel Transgenic Mice for Inducible Gene Overexpression in Pancreatic Cells Define Glucocorticoid Receptor-Mediated Regulations of Beta Cells
Bertrand Blondeau et al.
PLOS ONE (2012)
Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome
P. U. Feig et al.
DIABETES OBESITY & METABOLISM (2011)
Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study
Subodh Verma et al.
EUROPEAN HEART JOURNAL (2011)
The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
Julio Rosenstock et al.
DIABETES CARE (2010)
Aldosterone Production and Insulin Resistance in Healthy Adults
Rajesh Garg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Prevalence of metabolic syndrome among patients with schizophrenia in Japan
Norio Sugawara et al.
SCHIZOPHRENIA RESEARCH (2010)
Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
Yutaka Seino et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans
B. Ahren
DIABETOLOGIA (2008)
Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline
John W. Funder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The diagnosis of Cushing's syndrome: An endocrine society clinical practice guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
A possible association between primary aldosteronism and a lower β-cell function
Lorena M. Mosso et al.
JOURNAL OF HYPERTENSION (2007)
Effects of renin-angiotensin system inhibition on end-organ protection: Can we do better?
Matthew R. Weir
CLINICAL THERAPEUTICS (2007)
Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque
JJ Kulstad et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Prevalence of asymptomatic arteriosclerosis obliterans and its relationship with risk factors in inhabitants of rural communities in Japan: Tanno-Sobetsu study
T Fujiwara et al.
ATHEROSCLEROSIS (2004)
Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population - The Funagata study
M Daimon et al.
DIABETES CARE (2003)
Mechanisms involved in the side effects of glucocorticoids
H Schäcke et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Neuroendocrine abnormalities in visceral obesity
P Björntorp et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Share Paper
